Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 664.49M P/E - EPS this Y 10.00% Ern Qtrly Grth -
Income -41.53M Forward P/E -13.05 EPS next Y -16.70% 50D Avg Chg -4.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -14.00%
Dividend N/A Price/Book 4.54 EPS next 5Y - 52W High Chg -46.00%
Recommedations 2.00 Quick Ratio 11.95 Shares Outstanding 84.80M 52W Low Chg 10.00%
Insider Own 3.05% ROA -20.43% Shares Float 82.21M Beta 0.62
Inst Own 31.83% ROE -30.03% Shares Shorted/Prior 19.61M/19.75M Price 8.22
Gross Margin - Profit Margin - Avg. Volume 877,169 Target Price 35.47
Oper. Margin - Earnings Date Nov 25 Volume 616,765 Change 0.86%
About Anavex Life Sciences Corp.

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases. Its lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. The company's drug candidate also comprises ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.

Anavex Life Sciences Corp. News
10/31/24 Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024
10/17/24 Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
10/09/24 Anavex Life Sciences Corp (AVXL) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...
09/20/24 Anavex Life Sciences Corp. (NASDAQ:AVXL): Is Breakeven Near?
09/03/24 Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024
08/06/24 Anavex Life Sciences: Fiscal Q3 Earnings Snapshot
08/06/24 Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update
08/01/24 Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024
07/30/24 Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X Conference
07/29/24 Neurodegenerative Disease-Focused Anavex Life Sciences' Alzheimer's Candidate Slows Disease Progression By Almost 39%
07/29/24 Anavex seek EMA approval despite shaky pivotal Alzheimer’s trial data
07/28/24 Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference
07/09/24 Mirum (MIRM) Gets EC Approval for Livmarli Label Expansion
07/09/24 HilleVax (HLVX) Tanks as Norovirus Vaccine Study in Infants Fails
07/01/24 Institutions own 38% of Anavex Life Sciences Corp. (NASDAQ:AVXL) shares but individual investors control 59% of the company
06/20/24 Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
05/22/24 Sector Update: Health Care Stocks Slightly Higher Late Afternoon
05/22/24 Anavex Life Sciences Announces Expansion of Leadership Team
05/21/24 Anavex Life Sciences (NASDAQ:AVXL) Is In A Good Position To Deliver On Growth Plans
05/15/24 Anavex Life Sciences (AVXL) Upgraded to Buy: What Does It Mean for the Stock?
AVXL Chatroom

User Image Blarcamesine Posted - 44 minutes from now

$AVXL yes! Would like Accelerated Assessment!!

User Image Jsgribbs Posted - 22 minutes from now

$AVXL

User Image Maklik Posted - 33 minutes ago

$AVXL and how about you? What do you think?

User Image Blarcamesine Posted - 1 hour ago

$AVXL not any other company with an alzheimer's drug with great results and heading for approval !! $35 soon. . (This year seems likely)

User Image Blarcamesine Posted - 1 hour ago

$AVXL this is what Anavex said .

User Image Blarcamesine Posted - 1 hour ago

$AVXL Anavex stated earnings will be in December with a pr 1 week in advance. Annual reports have a 90 day window so it has to be Prior to 12/31. Last yr call was 11/27 .. i assume filing in Europe 1st maybe even a partnership then earnings.

User Image georgejjl Posted - 3 hours ago

$AVXL Anavex 3-71 (formerly known as AF710b) "...AF710B, its exceptional brain penetration and target engagement can be implied from the very high potency of the compound in in vivo studies. Notably, AF710B functions as a cognitive enhancer in the PA test involving trihexyphenidyl-treated rats at unprecedented low doses of 1–30µg/kg, po (Fig 1E). The effects of AF710B on cognition are enantioselective since the enantiomer AF710A is not active at 1 and 10 µg/kg, po (Table 1 and ?and2A).2A). Strong enantioselectivity of AF710B vs. AF710A was consistently observed in vitro and in vivo (Table 1). How does AF710B pharmacodynamics overcome existing compounds? We found that AF710B is the most potent cognitive enhancer and with the highest safety margin vs. a variety of compounds tested by us in the trihexyphenidyl model under same experimental protocols as tested for AF710B, including, inter alia, AF710A, AF102B, AF267B, AF292 and donepezil..." https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803577/ Good luck and GOD bless,

User Image DueBill Posted - 4 hours ago

$AVXL Nice close today… flying over Bimini … Not watching the market much today. Friends off shore like AVXL . Longs are in very good company. Be well friends.

User Image Homebody1 Posted - 4 hours ago

$AVXL It sure is odd that they haven't announced a date for the ER yet. It's possible this means somethings is in the works. This company delays data releases, lots of commitments, etc. but doesn't normally delay ER's. Last ER was 8/6.

User Image J903625 Posted - 4 hours ago

$AVXL 911

User Image papatrick Posted - 5 hours ago

$AVXL You know i am always joking since 2016...but one thing i know for sure is ...stock market and human behaves like nature...when its time for harvest its always wayyyyyyy larger than what you think. ....when apples are ready its not a container, its hundreds of containers......Missling is a strange animal but nature is nature and human like misslings remains in the law of natures...so expect a huge harvest soon...and thanks your god for that....i hope your god is not Missleading!

User Image kitty7kitty Posted - 6 hours ago

$AVXL Can somone please indulge me, educate me? I asked a question about shorting earlier when it was said that there are very few shares left to short, I asked what this meant and was told that this would drive the price down. But, is it possible that the whales bought up the short stocks available to accumulate and drive the stock up?

User Image kitty7kitty Posted - 6 hours ago

$AVXL

User Image OnlyUp01 Posted - 7 hours ago

$AVXL This may be a good sign although I wanted the shorts to get killed with an epic short squeeze. Not saying that still could not happen. Although I rather just have a nice slow and gradual increase in share price with occasional large gains but this is a clinical biotech. So, we'll likely get some massive days because this is a clinical biotech. I have 135,000 shares in my Fidelity account and let them lend them out to earn interest. At first I was like screw that but then I figured the shorts can pay me for their dumb decision. Periodically the number of shares would fluctuate but always most of the shares got lent out. Today is the first day ever that all 135,000 shares were returned. I'll take it as a good sign. The interest was nice while I waited for the golden goose which is the shares to appreciate in value. Anybody in a similar situation? Have an excellent weekend everyone including you bastard shorts. You're in for a world of hurt you dumb bastards!

User Image Blarcamesine Posted - 7 hours ago

$AVXL yes!! Soon!! Victory!

User Image RedShoulder Posted - 7 hours ago

@Brian5220 $AVXL 270k shares at the bell! $2,459,700 That is a big boat load of clams.

User Image RedShoulder Posted - 7 hours ago

@Series4Guy $AVXL 270k shares at the bell! $2,459,700 .....That is a boat load of clams

User Image 80proof Posted - 8 hours ago

$AVXL Get ready for an AVXL ENEMA shorts!

User Image g0eCK Posted - 8 hours ago

$AVXL 911= pending news, as it is :D https://www.reddit.com/r/Superstonk/comments/u7iox3/it_is_time_to_talk_about_market_maker_signals_i/

User Image badprecog Posted - 8 hours ago

$AVXL we were all born for this moment! We are on the cusp of total victory!!!

User Image Ricter59 Posted - 9 hours ago

$AVXL -9.11 close signal that the SP is going to explode. Lots of covering today!

User Image Blarcamesine Posted - 9 hours ago

$AVXL excellent!

User Image Series4Guy Posted - 10 hours ago

$AVXL attention all avxl shorts - this is going to hurt!

User Image Series4Guy Posted - 10 hours ago

$AVXL attention all avxl longs - the accumulation sale is almost over.

User Image Series4Guy Posted - 10 hours ago

$AVXL 270k shares at the bell!

User Image gnarled15 Posted - 10 hours ago

$AVXL great week.

User Image bartwood Posted - 11 hours ago

$AVXL

User Image Labrador47 Posted - 11 hours ago

$AVXL Is the earning call still Monday?

User Image gerardas Posted - 11 hours ago

$AVXL following fintel.io lots of shares were borrowed today for shorting, but AVXL still finished green (even if today is Friday). That's really good. What will be next week, maybe we will cross 10s?

User Image Blarcamesine Posted - 11 hours ago

$AVXL green is good!

Analyst Ratings
HC Wainwright & Co. Buy Aug 1, 24
EF Hutton Buy Jul 29, 24
EF Hutton Buy Jul 22, 24
HC Wainwright & Co. Buy Jun 11, 24
HC Wainwright & Co. Buy May 10, 24
HC Wainwright & Co. Buy Jan 3, 24
HC Wainwright & Co. Buy Nov 28, 23
HC Wainwright & Co. Buy Aug 8, 23
HC Wainwright & Co. Buy Jul 20, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
MISSLING CHRISTOPHER U President and CEO President and CEO Jun 28 Sell 7.98 268,000 2,138,640 1,018,210 06/30/23
MISSLING CHRISTOPHER U President and CEO President and CEO Jun 28 Option 1.6 500,000 800,000 1,250,210 06/30/23
Skarpelos Athanasios Director Director May 25 Option 0.92 50,000 46,000 1,356,458 05/27/22
Skarpelos Athanasios Director Director May 25 Sell 9.06 50,000 453,000 1,306,458 05/27/22
MISSLING CHRISTOPHER U President and CEO President and CEO Jul 01 Option 1.32 51,620 68,138 1,069,830 07/01/21
MISSLING CHRISTOPHER U President and CEO President and CEO Jul 01 Sell 26 51,620 1,342,120 1,018,210 07/01/21
Boenisch Sandra PFO and Treasurer PFO and Treasurer Jul 01 Option 4.96 166,696 826,812 189,659 07/01/21
Boenisch Sandra PFO and Treasurer PFO and Treasurer Jul 01 Sell 26.53 166,696 4,422,445 22,963 07/01/21
FAVUS ELLIOT Director Director May 25 Option 4.12 145,000 597,400 145,000 05/25/21
FAVUS ELLIOT Director Director May 25 Sell 11.7 145,000 1,696,500 05/25/21
FAVUS ELLIOT Director Director Feb 26 Option 2.93 145,500 426,315 145,000 02/26/21
FAVUS ELLIOT Director Director Feb 26 Sell 12.66 145,500 1,842,030 02/26/21
Donhauser Peter D.O. Director Director Feb 23 Buy 12.8 1,165 14,912 1,165 02/23/21